US equities
|
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Telix Pharmaceuticals Limited - American Depositary Shares
(NQ:
TLX
)
10.69
+0.12 (+1.14%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Telix Pharmaceuticals Limited - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
Next >
Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference
January 13, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
January 13, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
January 12, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
December 30, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
December 29, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete
December 19, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 12, 2024
Via
Benzinga
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
November 18, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >